A vaccine developed jointly by Gamaleya Research Institute and the Russian defence ministry is currently in its last stage
New Delhi: Russia is most likely to register its first vaccine against COVID-19 on August 12, the country's deputy health minister Oleg Gridnev said on Friday, according to a report.
The much-awaited vaccine has been developed jointly by the Gamaleya Research Institute and the Russian defence ministry.
The last stage for the vaccine is underway, and once it is found fully safe, medical professionals and senior citizens will be the first to get vaccinated.
The effectiveness of the vaccine will be judged when the population immunity has formed.
Clinical trials of this vaccine began on June 18 and included 38 volunteers. According to reports, all participants have developed immunity. The first group was discharged on July 15 and the second group on July 20. However, Russia is yet to publish any scientific data from its first clinical trials.
Meanwhile, World Health Organisation (WHO) has urged Russia to follow established guidelines for producing safe and effective vaccines after Moscow announced plans to swiftly start producing COVID-19 vaccines.